NEW STUDY - Circulating Spike Protein Detectable 709 Days after COVID-19 mRNA Injection

Participants with post-vaccination syndrome had significantly higher circulating Spike protein levels compared with the control group.

by Nicolas Hulscher, MPH

The study titled, Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination, was just uploaded to the medRxiv preprint server:

Abstract

… a small fraction of the population reports a chronic debilitating condition after COVID-19 vaccination, often referred to as post- vaccination syndrome (PVS). To explore potential pathobiological features associated with PVS, we conducted a decentralized, cross-sectional study involving 42 PVS participants and 22 healthy controls enrolled in the Yale LISTEN study. Compared with controls, PVS participants exhibited differences in immune profiles, including reduced circulating memory and effector CD4 T cells (type 1 and type 2) and an increase in TNFα+ CD8 T cells. PVS participants also had lower anti-spike antibody titers, primarily due to fewer vaccine doses. Serological evidence of recent Epstein-Barr virus (EBV) reactivation was observed more frequently in PVS participants. Further, individuals with PVS exhibited elevated levels of circulating spike protein compared to healthy controls. These findings reveal potential immune differences in individuals with PVS that merit further investigation to better understand this condition and inform future research into diagnostic and therapeutic approaches.

The most striking finding from this study is that circulating Spike protein was detectable up to 709 days after COVID-19 mRNA Injection:

They also found that “participants with PVS had significantly higher circulating S1 levels compared with the control group (p = 0.01).” The study further confirmed that the presence of S1 reflects the presence of full-length (‘vaccine’) Spike protein:

The full-length S SPEAR assays showed a significant correlation between S and S1 across all samples (Fig. 5E), as well as for values above the LLoD and LLoQ (Fig. 5F, Table S2). Thus, based on SPEAR assays, the individuals with PVS exhibited elevated levels of circulating full-length S compared to healthy controls.

These data help to explain delayed adverse events and long-term harms from COVID-19 mRNA injections, especially given that 320 peer-reviewed scientific studies confirm that the Spike protein is highly pathogenic on its own. The findings also support the use of Spike protein detoxification methods in the resolution of COVID-19 ‘vaccine’ injury syndromes, such as McCullough Protocol: Base Spike Detoxification:

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.